CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV
Delisted
CORV was delisted on the 26th of May, 2020.
24 hedge funds and large institutions have $60M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
71% less call options, than puts
Call options by funds: $23K | Put options by funds: $78K
Holders
24
Holding in Top 10
1
Calls
$23K
Puts
$78K
Top Buyers
| 1 | +$1.14M | |
| 2 | +$326K | |
| 3 | +$200K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$88.2K |
| 5 |
Morgan Stanley
New York
|
+$44.6K |
Top Sellers
| 1 | -$3.42M | |
| 2 | -$44K | |
| 3 | -$37.8K | |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$35K |
| 5 |
LPL Financial
San Diego,
California
|
-$29K |